282 related articles for article (PubMed ID: 28744860)
1. Echinocandins in antifungal pharmacotherapy.
Patil A; Majumdar S
J Pharm Pharmacol; 2017 Dec; 69(12):1635-1660. PubMed ID: 28744860
[TBL] [Abstract][Full Text] [Related]
2. Echinocandins: the newest class of antifungals.
Sucher AJ; Chahine EB; Balcer HE
Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
[TBL] [Abstract][Full Text] [Related]
3. The echinocandins.
Cappelletty D; Eiselstein-McKitrick K
Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
[TBL] [Abstract][Full Text] [Related]
4. The echinocandins: three useful choices or three too many?
Bal AM
Int J Antimicrob Agents; 2010 Jan; 35(1):13-8. PubMed ID: 19942413
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacodynamics and pharmacokinetics of micafungin in adults, children and neonate].
Catalán-González M; Carlos Montejo-González J
Rev Iberoam Micol; 2009 Mar; 26(1):23-34. PubMed ID: 19463274
[TBL] [Abstract][Full Text] [Related]
6. Echinocandins: The Expanding Antifungal Armamentarium.
Aguilar-Zapata D; Petraitiene R; Petraitis V
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S604-11. PubMed ID: 26567277
[TBL] [Abstract][Full Text] [Related]
7. [Micafungin: experimental therapy of fungal infections in animal models].
Javier Pastor F; Guarro J
Rev Iberoam Micol; 2009 Mar; 26(1):42-8. PubMed ID: 19463276
[TBL] [Abstract][Full Text] [Related]
8. Echinocandin use in the neonatal intensive care unit.
Caudle KE; Inger AG; Butler DR; Rogers PD
Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
[TBL] [Abstract][Full Text] [Related]
9. Role of micafungin in the antifungal armamentarium.
Ikeda F; Tanaka S; Ohki H; Matsumoto S; Maki K; Katashima M; Barrett D; Aoki Y
Curr Med Chem; 2007; 14(11):1263-75. PubMed ID: 17504145
[TBL] [Abstract][Full Text] [Related]
10. Advances in systemic antifungal therapy.
Stevens DA
Clin Dermatol; 2012; 30(6):657-61. PubMed ID: 23068153
[TBL] [Abstract][Full Text] [Related]
11. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
Agarwal MB; Rathi SA; Ratho N; Subramanian R
J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012
[TBL] [Abstract][Full Text] [Related]
12. Caspofungin.
Parakh A; Dubey AP; Samanta D
Indian Pediatr; 2008 Nov; 45(11):905-10. PubMed ID: 19029563
[TBL] [Abstract][Full Text] [Related]
13. Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections.
Scott LJ
Drugs; 2012 Nov; 72(16):2141-65. PubMed ID: 23083111
[TBL] [Abstract][Full Text] [Related]
14. [Drug interactions in critically-ill patients. An important factor in the use of micafungin?].
Garnacho-Montero J; Jiménez Parrilla F
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():33-7. PubMed ID: 21420575
[TBL] [Abstract][Full Text] [Related]
15. [Echinocandins].
Cortés L JA; Russi N JA
Rev Chilena Infectol; 2011 Dec; 28(6):529-36. PubMed ID: 22286675
[TBL] [Abstract][Full Text] [Related]
16. A clinical review of echinocandins in pediatric patients.
VandenBussche HL; Van Loo DA
Ann Pharmacother; 2010 Jan; 44(1):166-77. PubMed ID: 20009006
[TBL] [Abstract][Full Text] [Related]
17. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
Salavert-Lletí M; Zaragoza-Crespo R
Rev Iberoam Micol; 2009 Mar; 26(1):81-9. PubMed ID: 19463284
[TBL] [Abstract][Full Text] [Related]
18. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections.
Groll AH; Walsh TJ
Expert Opin Investig Drugs; 2001 Aug; 10(8):1545-58. PubMed ID: 11772269
[TBL] [Abstract][Full Text] [Related]
19. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
20. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Fera MT; La Camera E; De Sarro A
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]